189 related articles for article (PubMed ID: 12939460)
1. Arsenic trioxide induces apoptosis in peripheral blood T lymphocyte subsets by inducing oxidative stress: a role of Bcl-2.
Gupta S; Yel L; Kim D; Kim C; Chiplunkar S; Gollapudi S
Mol Cancer Ther; 2003 Aug; 2(8):711-9. PubMed ID: 12939460
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells.
Baysan A; Yel L; Gollapudi S; Su H; Gupta S
Int J Oncol; 2007 Feb; 30(2):313-8. PubMed ID: 17203211
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
Li JJ; Tang Q; Li Y; Hu BR; Ming ZY; Fu Q; Qian JQ; Xiang JZ
Acta Pharmacol Sin; 2006 Aug; 27(8):1078-84. PubMed ID: 16867262
[TBL] [Abstract][Full Text] [Related]
4. Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells.
Haga N; Fujita N; Tsuruo T
Cancer Sci; 2005 Nov; 96(11):825-33. PubMed ID: 16271077
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells.
Sturlan S; Baumgartner M; Roth E; Bachleitner-Hofmann T
Blood; 2003 Jun; 101(12):4990-7. PubMed ID: 12609832
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage.
Mahieux R; Pise-Masison C; Gessain A; Brady JN; Olivier R; Perret E; Misteli T; Nicot C
Blood; 2001 Dec; 98(13):3762-9. PubMed ID: 11739184
[TBL] [Abstract][Full Text] [Related]
7. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways.
Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P
Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide (As(2)O(3)) induces apoptosis through activation of Bax in hematopoietic cells.
Zheng Y; Yamaguchi H; Tian C; Lee MW; Tang H; Wang HG; Chen Q
Oncogene; 2005 May; 24(20):3339-47. PubMed ID: 15735709
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.
Ramos AM; Fernández C; Amrán D; Sancho P; de Blas E; Aller P
Blood; 2005 May; 105(10):4013-20. PubMed ID: 15665116
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
14. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.
Zheng Y; Zhou M; Ye A; Li Q; Bai Y; Zhang Q
World J Surg Oncol; 2010 Apr; 8():31. PubMed ID: 20403207
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt.
Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK
Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines.
Nakagawa Y; Akao Y; Morikawa H; Hirata I; Katsu K; Naoe T; Ohishi N; Yagi K
Life Sci; 2002 Mar; 70(19):2253-69. PubMed ID: 12005185
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione.
Xiao G; Tang X; Yao C; Wang C
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):712-21. PubMed ID: 21785114
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells.
Kumar S; Yedjou CG; Tchounwou PB
J Exp Clin Cancer Res; 2014 May; 33(1):42. PubMed ID: 24887205
[TBL] [Abstract][Full Text] [Related]
19. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria.
Kang YH; Yi MJ; Kim MJ; Park MT; Bae S; Kang CM; Cho CK; Park IC; Park MJ; Rhee CH; Hong SI; Chung HY; Lee YS; Lee SJ
Cancer Res; 2004 Dec; 64(24):8960-7. PubMed ID: 15604259
[TBL] [Abstract][Full Text] [Related]
20. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
